These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37196069)

  • 1. Hypofractionated Stereotactic Re-irradiation and 
Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results.
    Pouessel D; Ken S; Gouaze-Andersson V; Piram L; Mervoyer A; Larrieu-Ciron D; Cabarrou B; Lusque A; Robert M; Frenel JS; Uro-Coste E; Olivier P; Mounier M; Sabatini U; Sanchez EH; Zouitine M; Berjaoui A; Cohen-Jonathan Moyal E
    Oncologist; 2023 Sep; 28(9):825-e817. PubMed ID: 37196069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
    Clarke J; Neil E; Terziev R; Gutin P; Barani I; Kaley T; Lassman AB; Chan TA; Yamada J; DeAngelis L; Ballangrud A; Young R; Panageas KS; Beal K; Omuro A
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):797-804. PubMed ID: 28870792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recurrent glioblastoma with stereotactic radiotherapy: long-term results of a mono-institutional trial.
    Maranzano E; Anselmo P; Casale M; Trippa F; Carletti S; Principi M; Loreti F; Italiani M; Caserta C; Giorgi C
    Tumori; 2011; 97(1):56-61. PubMed ID: 21528665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).
    Oehlke O; Mix M; Graf E; Schimek-Jasch T; Nestle U; Götz I; Schneider-Fuchs S; Weyerbrock A; Mader I; Baumert BG; Short SC; Meyer PT; Weber WA; Grosu AL
    BMC Cancer; 2016 Oct; 16(1):769. PubMed ID: 27716184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study.
    Sahebjam S; Forsyth PA; Tran ND; Arrington JA; Macaulay R; Etame AB; Walko CM; Boyle T; Peguero EN; Jaglal M; Mokhtari S; Enderling H; Raghunand N; Gatewood T; Long W; Dzierzeski JL; Evernden B; Robinson T; Wicklund MC; Kim S; Thompson ZJ; Chen DT; Chinnaiyan P; Yu HM
    Neuro Oncol; 2021 Apr; 23(4):677-686. PubMed ID: 33173935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-Irradiation with Stereotactic Radiosurgery/Radiotherapy for Recurrent High-Grade Gliomas: Improved Survival in the Modern Era.
    Gigliotti MJ; Hasan S; Karlovits SM; Ranjan T; Wegner RE
    Stereotact Funct Neurosurg; 2018; 96(5):289-295. PubMed ID: 30404102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.
    Vordermark D; Kölbl O; Ruprecht K; Vince GH; Bratengeier K; Flentje M
    BMC Cancer; 2005 May; 5():55. PubMed ID: 15924621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years' experience of a single center.
    Yilmaz MT; Kahvecioglu A; Yazici G; Mohammadipour S; Kertmen N; Cifci GC; Zorlu F
    J Neurooncol; 2024 Apr; 167(2):295-303. PubMed ID: 38383875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic parameters and outcome after re-irradiation for progressive glioblastoma.
    Zwirner K; Paulsen F; Schittenhelm J; Borchers C; Skardelly M; Zips D; Eckert F
    Acta Neurol Scand; 2017 Sep; 136(3):239-245. PubMed ID: 28025828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Radiotherapy in Recurrent Glioblastoma: A Valid Salvage Treatment Option.
    Yaprak G; Isık N; Gemici C; Pekyurek M; Ceylaner Bıcakcı B; Demircioglu F; Tatarlı N
    Stereotact Funct Neurosurg; 2020; 98(3):167-175. PubMed ID: 32248188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
    Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractionated stereotactic re-irradiation for recurrent glioblastoma: A systematic review and meta-analysis.
    Luo T; Feng J; Sun P
    Clin Neurol Neurosurg; 2023 Jun; 229():107728. PubMed ID: 37105068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-irradiation of recurrent glioblastoma multiforme using 11C-methionine PET/CT/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy.
    Miwa K; Matsuo M; Ogawa S; Shinoda J; Yokoyama K; Yamada J; Yano H; Iwama T
    Radiat Oncol; 2014 Aug; 9():181. PubMed ID: 25123357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis.
    Kazmi F; Soon YY; Leong YH; Koh WY; Vellayappan B
    J Neurooncol; 2019 Mar; 142(1):79-90. PubMed ID: 30523605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-irradiation with radiosurgery for recurrent glioblastoma multiforme.
    Torok JA; Wegner RE; Mintz AH; Heron DE; Burton SA
    Technol Cancer Res Treat; 2011 Jun; 10(3):253-8. PubMed ID: 21517131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?
    Fokas E; Wacker U; Gross MW; Henzel M; Encheva E; Engenhart-Cabillic R
    Strahlenther Onkol; 2009 Apr; 185(4):235-40. PubMed ID: 19370426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Retrospective Review of Re-irradiating Patients' Recurrent High-grade Gliomas.
    Klobukowski L; Falkov A; Chelimo C; Fogh SE
    Clin Oncol (R Coll Radiol); 2018 Sep; 30(9):563-570. PubMed ID: 29891395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase II Trial of Concurrent Temozolomide and Hypofractionated Stereotactic Radiotherapy for Complex Brain Metastases.
    Bi N; Ma Y; Xiao J; Zhang H; Xu Y; Tian Y; Li J; Zhang Y; Liu Q; Wang K; Deng L; Wang W; Chen X; Liu F; Zhao R; Yang S; Huang X; Yi J; Hu C; Li Y
    Oncologist; 2019 Sep; 24(9):e914-e920. PubMed ID: 30996008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of patients with recurrent glioblastoma using hypofractionated stereotactic radiotherapy.
    Dincoglan F; Beyzadeoglu M; Sager O; Demiral S; Gamsiz H; Uysal B; Ebruli C; Akin M; Oysul K; Sirin S; Dirican B
    Tumori; 2015; 101(2):179-84. PubMed ID: 25791534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated Stereotactic Radiotherapy for Patients with Intracranial Meningiomas: impact of radiotherapy regimen on local control.
    Meniai-Merzouki F; Bernier-Chastagner V; Geffrelot J; Tresch E; Lacornerie T; Coche-Dequeant B; Lartigau E; Pasquier D
    Sci Rep; 2018 Sep; 8(1):13666. PubMed ID: 30209337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.